Advanced Search

 

Study ID Status Title Patient Level Data
999910/117 Completed Study to evaluate the immune response induced by DTPa/Hib and meningococcal C conjugate vaccines when given as a three-dose primary vaccination course in infants at 2, 3 and 4 months of age
999910/124 Completed A double blind, randomised, cross-over study to assess lamotrigine modulation of ketamine effects using functional magnetic resonance imaging in healthy male volunteers
999910/126 Completed A placebo-controlled, randomised, double-blinded, parallel group study in healthy volunteers to assess the effects of paroxetine on ejaculation and accompanying neurohumoral parameters.
999910/150 Completed A study in patients with Crohn's Disease to evaluate the effect of AVANDIA™ on inflammatory activity mediated by monocytes/macrophages.
999910/189 Completed A comparison of the effects of AVANDIA® on arterial stiffness in obese subjects and healthy non-obese control subjects
999910/193 Completed Prospective, Hospital-based, Multicentre Study to Assess the Incidence of Intussusception in Children < 2 Years of Age in Singapore
999910/196 Completed A randomized, placebo-controlled, single blind, 4 way cross-over study to investigate the effects of a single dose of Avandia® on renal function in healthy male volunteers.
A1900832 Completed A Pharmacokinetic Study to Evaluate the Rate and Extent of Absorption of Paracetamol from Two Formulations in an Indian Population.
A1901106 Completed A Study to Investigate the Gastrointestinal Safety of OTC Analgesics in Healthy Volunteers by Endoscopic Examination
A2260597 Terminated A study to assess the efficacy of paracetamol taken in combination with caffeine for the treatment of episodic tension type headache
A2260665 Completed A pivotal pharmacokinetic study investigating the extent of absorptions of paracetamol and caffeine for two different paracetomol formulations containing caffeine
A2750596 Completed A study investigating the pharmacokinetic profiles of four extended release paracetamol formulations
A2750605 Completed A single dose PK study investigating the extent of paracetamol absorption from two different sustained released paracetamol formulations
A2750606 Completed A single dose PK study investigating the extent of paracetamol absorption from two sustained release paracetamol formulations
A2750607 Completed A repeat dose PK study investigating the extent of paracetamol absorption from two sustained release paracetamol formulations
A2750894 Completed A Proof of Principal Study to Investigate the Pharmacokinetic Profiles of Sustained Release and Standard Paracetamol Formulations
A3360529 Completed A randomised, double-blind, evaluation of the effects of paracetamol on the BOLD fMRI response to painful stimuli in subjects with osteoarthritis
A3940666 Completed A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain
A3950669 Completed A pharmacokinetic study investigating the rate and extent of paracetamol absorption of three experimental sustained release pediatric suspensions
A4000684 Completed A study to compare the analgesic efficacy of two different paracetamol doses as measured by post-operative dental pain relief
A4000685 Completed A study to compare the analgesic efficacy of two different paracetamol doses as measured by post-operative pain relief
A4010001 Completed A two centre, randomised, partially double-blind, double dummy, placebo-controlled, crossover study to investigate the effects of pre-treatment with a new chemical entity (NCE) and a single inhaled dose of fluticasone propionate (0.5 mg) on the allergen induced late asthmatic response in mild as ...
A4A10003 Completed A randomised, double-blind, placebo-controlled, 3-way cross-over study to investigate the effects of pre-treatment with single inhaled doses of an NCE and fluticasone propionate on the allergen induced late phase asthmatic response in mild asthmatic subjects. Study Listed on ClinicalStudyDataRequest.com
A4A10008 Completed An 8-day, randomised, placebo-controlled, three-way crossover trial of repeat doses of a new chemical entity (NCE), fluticasone propionate and placebo administered intranasally, blinded for fluticasone propionate versus placebo, in an environmental exposition unit, the Vienna Challenge Chamber (VCC) in subjects with seasonal allergic rhinitis (SAR) Study Listed on ClinicalStudyDataRequest.com
A4M105038 Completed Randomised, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study to Investigate the MRI Efficacy and the Safety of Six Months Administration of SB-683699 in Subjects with Relapsing-Remitting Multiple Sclerosis

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.